Hallmark star secretly battles throat cancer

Hallmark star John Reardon reveals he had tonsil cancer: ‘Has been a long road.'
John Reardon has revealed that he was diagnosed with tonsil cancer. The Canadian actor, 49, has starred in Citytv's “Hudson & Rex" since 2019, and is also known for his roles in Hallmark Christmas films such as “Believe in Christmas,” which premiered last month.
Hallmark star secretly battles throat cancer, says he's been on a 'long road' to recovery
Actor John Reardon, known for his role in the Hallmark movie "Believe in Christmas," shared a health update on social media as he posted a photo of himself hospitalized after he revealed he had throat cancer.
Hallmark star John Reardon shares recovery from tonsil cancer
The Hallmark actor known for roles in "Believe in Christmas" and the TV series "Hudson & Rex" thanked his family and medical staff for their support amid his recovery.
Hallmark Star John Reardon Shares Tonsil Cancer Diagnosis In Emotional Social Media Post: It’s “Been A Long Road”
Believe in Christmas star John Reardon announced he is currently recovering from tonsil cancer in an emotional social media post thanking his loved ones for their support. The Hallmark star shared a photo from the hospital on Instagram,
Hallmark Stars John Reardon and Meghan Ory's Relationship Timeline
John Reardon and Meghan Ory didn't meet on a Hallmark Channel movie - but their love story plays out like one. The twosome were introduced while filming their short-lived series Merlin's Apprentice in 2006.
Pharmaceutical Technology1h
HPV-16 E7 by Gilead Sciences for Oropharyngeal Cancer: Likelihood of Approval
HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Oropharyngeal Cancer.
verywellhealth on MSN12d
The HPV Vaccine Protects Against More Than Just Cervical Cancer, Experts Say
Most Americans are unaware of the link between HPV and throat cancer, despite the virus causing 70% of cases. With low ...
Health on MSN7d
Study Finds Many Americans Don't Know That HPV Can Cause This Type of Cancer
Public awareness of the dangers of HPV and the benefits of the vaccine are low, according to two recent students. Experts ...
Pharmaceutical Technology1h
NPG-2044 by Novita Pharmaceuticals for Oropharyngeal Cancer: Likelihood of Approval
NPG-2044 is under clinical development by Novita Pharmaceuticals and currently in Phase II for Oropharyngeal Cancer.
McKnight's Long-Term Care News3d
Risk for head and neck cancer lower for coffee and tea drinkers
Coffee and tea drinkers have a reduced risk for head and neck cancer (HNC), according to research published online Dec. 23 in ...
HealthDay on MSN12d
Many Lack Knowledge of Link Between HPV and Oropharyngeal Cancer
Knowledge of the association between human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma (OPSCC) is ...
Business Insider21d
EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024
EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024 Paris, France, 9 December 2024 – EnnoDC, a clinical-stage biotech company ...